Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Biomaterials. 2011 Jan;32(1):231–238. doi: 10.1016/j.biomaterials.2010.08.080

Fig. 1.

Fig. 1

Characterization of NF-κB inhibiting PFC nanoparticles generated with the use of a linker peptide. (A). Sequence of the NBD peptide conjugated on the N-terminal of the linker peptide (Italic) with two Glycines. (B). Mean hydrodynamic diameter and zeta potential of nanoparticles with or without incorporation of NBD-Linker, respectively. (C). Transmission electron micrograph of PFC nanoparticles incorporated with NBD-Linker. Scale bar represents 250 nm (D). A schematic illustration of PFC nanoparticle with enlarged NBD-Linkers incorporated in the lipid monolayer.